The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Alessandro Serretti

Department of Psychiatry

Vita-Salute University

San Raffaele Institute

Milan

Italy

[email]@hsr.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Psychiatry, Vita-Salute University, San Raffaele Institute, Milan, Italy. 2001 - 2006
  • Department of Psychiatry, Istituto Scientifico H San Raffaele, Vita-Salute University, Via Stamira D'Ancona 20, Italy. 2001 - 2005
  • Department of Neuropsychiatric Sciences, Istituto Scientifico, Universitario Ospedale San Raffaele, University of Milan School of Medicine, Italy. 2005
  • Istituto Scientifico H San Raffaele, Department of Neuroscience, University of Milano School of Medicine, Milan, Italy. 1999 - 2004

References

  1. Influence of postpartum onset on the course of mood disorders. Serretti, A., Olgiati, P., Colombo, C. BMC. Psychiatry (2006) [Pubmed]
  2. Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms. Serretti, A., Mandelli, L., Lorenzi, C., Landoni, S., Calati, R., Insacco, C., Cloninger, C.R. Neuropsychobiology (2006) [Pubmed]
  3. Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis. Serretti, A., Cusin, C., Rausch, J.L., Bondy, B., Smeraldi, E. Psychiatry. Res (2006) [Pubmed]
  4. Profiles of "manic" symptoms in bipolar I, bipolar II and major depressive disorders. Serretti, A., Olgiati, P. J. Affect. Disord (2005) [Pubmed]
  5. Social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects. Serretti, A., Mandelli, L., Lorenzi, C., Smeraldi, E. Psychiatry. Res (2005) [Pubmed]
  6. Pharmacogenetics in the treatment of depression: pharmacodynamic studies. Serretti, A., Artioli, P., Quartesan, R. Pharmacogenet. Genomics (2005) [Pubmed]
  7. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Serretti, A., Benedetti, F., Zanardi, R., Smeraldi, E. Prog. Neuropsychopharmacol. Biol. Psychiatry (2005) [Pubmed]
  8. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Serretti, A., Cusin, C., Benedetti, F., Mandelli, L., Pirovano, A., Zanardi, R., Colombo, C., Smeraldi, E. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2005) [Pubmed]
  9. Components of self-esteem in affective patients and non-psychiatric controls. Serretti, A., Olgiati, P., Colombo, C. J. Affect. Disord (2005) [Pubmed]
  10. Genes involved in Alzheimer's disease, a survey of possible candidates. Serretti, A., Artioli, P., Quartesan, R., De Ronchi, D. J. Alzheimers Dis. (2005) [Pubmed]
  11. New antipsychotics and schizophrenia: a review on efficacy and side effects. Serretti, A., De Ronchi, D., Lorenzi, C., Berardi, D. Curr. Med. Chem. (2004) [Pubmed]
  12. The 5-HT2C receptor as a target for mood disorders. Serretti, A., Artioli, P., De Ronchi, D. Expert Opin. Ther. Targets (2004) [Pubmed]
  13. From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes. Serretti, A., Artioli, P. Psychopharmacology (Berl.) (2004) [Pubmed]
  14. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders. Serretti, A., Malitas, P.N., Mandelli, L., Lorenzi, C., Ploia, C., Alevizos, B., Nikolaou, C., Boufidou, F., Christodoulou, G.N., Smeraldi, E. Pharmacogenomics J. (2004) [Pubmed]
  15. Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder. Serretti, A., Artioli, P., Zanardi, R., Lorenzi, C., Rossini, D., Cusin, C., Arnoldi, A., Catalano, M. Psychopharmacology (Berl.) (2004) [Pubmed]
  16. Depressive syndrome in major psychoses: a study on 1351 subjects. Serretti, A., Mandelli, L., Lattuada, E., Smeraldi, E. Psychiatry. Res (2004) [Pubmed]
  17. Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders. Serretti, A., Cusin, C., Rossini, D., Artioli, P., Dotoli, D., Zanardi, R. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2004) [Pubmed]
  18. DRD4 exon 3 variants are not associated with symptomatology of major psychoses in a German population. Serretti, A., Lorenzi, C., Mandelli, L., Cichon, S., Schumacher, J., Nöthen, M.M., Rietschel, M., Tullius, M., Ohlraun, S. Neurosci. Lett. (2004) [Pubmed]
  19. The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Serretti, A., Artioli, P., Lorenzi, C., Pirovano, A., Tubazio, V., Zanardi, R. Int. J. Neuropsychopharmacol. (2004) [Pubmed]
  20. Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up. Serretti, A., Zanardi, R., Franchini, L., Artioli, P., Dotoli, D., Pirovano, A., Smeraldi, E. Pharmacogenetics (2004) [Pubmed]
  21. Neural network analysis in pharmacogenetics of mood disorders. Serretti, A., Smeraldi, E. BMC Med. Genet. (2004) [Pubmed]
  22. Predicting response to lithium in mood disorders: role of genetic polymorphisms. Serretti, A., Artioli, P. Am. J. Pharmacogenomics (2003) [Pubmed]
  23. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Serretti, A., Benedetti, F., Mandelli, L., Lorenzi, C., Pirovano, A., Colombo, C., Smeraldi, E. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2003) [Pubmed]
  24. Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder. Serretti, A., Artioli, P., Zanardi, R., Rossini, D. Prog. Neuropsychopharmacol. Biol. Psychiatry (2003) [Pubmed]
  25. Pharmacogenetics in affective disorders. Serretti, A., Lilli, R., Smeraldi, E. Eur. J. Pharmacol. (2002) [Pubmed]
  26. Lithium long-term treatment in mood disorders: clinical and genetic predictors. Serretti, A. Pharmacogenomics (2002) [Pubmed]
  27. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Serretti, A., Cristina, S., Lilli, R., Cusin, C., Lattuada, E., Lorenzi, C., Corradi, B., Grieco, G., Costa, A., Santorelli, F., Barale, F., Nappi, G., Smeraldi, E. Am. J. Med. Genet. (2002) [Pubmed]
  28. Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants. Serretti, A., Lorenzi, C., Lilli, R., Mandelli, L., Pirovano, A., Smeraldi, E. Am. J. Med. Genet. (2002) [Pubmed]
  29. Clinical and demographic features of mood disorder subtypes. Serretti, A., Mandelli, L., Lattuada, E., Cusin, C., Smeraldi, E. Psychiatry. Res (2002) [Pubmed]
  30. DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects. Serretti, A., Lilli, R., Lorenzi, C., Lattuada, E., Smeraldi, E. Am. J. Med. Genet. (2001) [Pubmed]
  31. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Serretti, A., Zanardi, R., Rossini, D., Cusin, C., Lilli, R., Smeraldi, E. Mol. Psychiatry (2001) [Pubmed]
  32. Major psychoses symptomatology: factor analysis of 2241 psychotic subjects. Serretti, A., Rietschel, M., Lattuada, E., Krauss, H., Schulze, T.G., Müller, D.J., Maier, W., Smeraldi, E. Eur. Arch. Psychiatry. Clin. Neurosci (2001) [Pubmed]
  33. No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors. Serretti, A., Zanardi, R., Cusin, C., Rossini, D., Lilli, R., Lorenzi, C., Lattuada, E., Smeraldi, E. Psychiatry. Res (2001) [Pubmed]
  34. Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Serretti, A., Lilli, R., Mandelli, L., Lorenzi, C., Smeraldi, E. Pharmacogenomics J. (2001) [Pubmed]
  35. Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia. Serretti, A., Cusin, C., Lorenzi, C., Lattuada, E., Lilli, R., Smeraldi, E. Am. J. Med. Genet. (2000) [Pubmed]
  36. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders. Serretti, A., Lorenzi, C., Lilli, R., Smeraldi, E. J. Psychiatr. Res (2000) [Pubmed]
  37. Linkage of mood disorders with D2, D3 and TH genes: a multicenter study. Serretti, A., Macciardi, F., Cusin, C., Lattuada, E., Souery, D., Lipp, O., Mahieu, B., Van Broeckhoven, C., Blackwood, D., Muir, W., Aschauer, H.N., Heiden, A.M., Ackenheil, M., Fuchshuber, S., Raeymaekers, P., Verheyen, G., Kaneva, R., Jablensky, A., Papadimitriou, G.N., Dikeos, D.G., Stefanis, C.N., Smeraldi, E., Mendlewicz, J. J. Affect. Disord (2000) [Pubmed]
  38. Patterns of symptom improvement during antidepressant treatment of delusional depression. Serretti, A., Lattuada, E., Zanardi, R., Franchini, L., Smeraldi, E. Psychiatry. Res (2000) [Pubmed]
  39. Melancholic features and response to lithium prophylaxis in mood disorders. Serretti, A., Lattuada, E., Franchini, L., Smeraldi, E. Depress. Anxiety (2000) [Pubmed]
  40. Serotonin-2C and serotonin-1A receptor genes are not associated with psychotic symptomatology of mood disorders. Serretti, A., Lilli, R., Lorenzi, C., Lattuada, E., Smeraldi, E. Am. J. Med. Genet. (2000) [Pubmed]
  41. Serotonin transporter gene not associated with psychotic symptomatology of mood disorders. Serretti, A., Lattuada, E., Catalano, M., Smeraldi, E. Psychiatry. Res (1999) [Pubmed]
  42. No association between serotonin-2A receptor gene polymorphism and psychotic symptomatology of mood disorders. Serretti, A., Lilli, R., Lorenzi, C., Smeraldi, E. Psychiatry. Res (1999) [Pubmed]
  43. Dopamine D3 receptor gene not associated with symptomatology of major psychoses. Serretti, A., Lattuada, E., Cusin, C., Lilli, R., Lorenzi, C., Smeraldi, E. Am. J. Med. Genet. (1999) [Pubmed]
  44. No interaction between serotonin transporter gene and dopamine receptor D4 gene in symptomatology of major psychoses. Serretti, A., Cusin, C., Lattuada, E., Lilli, R., Lorenzi, C., Di Bella, D., Catalano, M., Smeraldi, E. Am. J. Med. Genet. (1999) [Pubmed]
  45. Dopamine receptor D4 gene is not associated with major psychoses. Serretti, A., Lilli, R., Di Bella, D., Bertelli, S., Nobile, M., Novelli, E., Catalano, M., Smeraldi, E. Am. J. Med. Genet. (1999) [Pubmed]
  46. Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders. Serretti, A., Lilli, R., Lorenzi, C., Gasperini, M., Smeraldi, E. J. Psychiatr. Res (1999) [Pubmed]
  47. Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders. Serretti, A., Lilli, R., Lorenzi, C., Franchini, L., Di Bella, D., Catalano, M., Smeraldi, E. Psychiatry. Res (1999) [Pubmed]
  48. Outcome of affective psychosis. Serretti, A., Lattuada, E., Smeraldi, E. Depress. Anxiety (1999) [Pubmed]
  49. Delineating psychopathologic clusters within dysthymia: a study of 512 out-patients without major depression. Serretti, A., Jori, M.C., Casadei, G., Ravizza, L., Smeraldi, E., Akiskal, H. J. Affect. Disord (1999) [Pubmed]
  50. Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation. Serretti, A., Benedetti, F., Colombo, C., Lilli, R., Lorenzi, C., Smeraldi, E. Psychiatry. Res (1999) [Pubmed]
 
WikiGenes - Universities